February 25, 2014

DSN recently caught up with Dick Domann, VP pharmacy services for TrialCard, to talk about adherence and abandonment solutions. Capturing otherwise lost scripts is a significant opportunity for retail pharmacy, and TrialCard has a tool to help reclaim those prescriptions.

January 8, 2014

News stories about doctor shopping and prescription pad pilfering in pursuit of a pain-pill induced high have become commonplace, prompting many legislators and regulators to consider further restrictions on pain medicines like hydrocodone compounds. But there may be a story that’s not being told — that the patients who suffer from chronic pain and need that hydrocodone to reclaim their lives are being stigmatized. The prevalence of pain pill abuse has left in its wake as many as 116 million legitimate pain sufferers who are finding it more difficult to access their therapies.

August 27, 2013

How can retail pharmacy play a greater role in battling the nation's prescription drug abuse epidemic? Data. To shed light on how CVS Caremark tapped its extensive prescribing database to identify signs of potential inappropriate prescribing, CVS Caremark¹s Troy Brennan talked with DSN about the program and the ongoing efforts to combat prescription drug abuse.

August 20, 2013

A pair of pharmacists from Whitsett, N.C., were the winners of a special text-to-vote competition to highlight independent pharmacy best practices at the Cardinal Health 2013 Retail Business Conference.

August 5, 2013

Rob Hooper, national sales manager for OTC with Actavis Pharmaceutical, sat down with DSN to discuss how Actavis is preparing for the inaugural NACDS Total Store Expo. Actavis Pharmaceutical, one of the leaders in the OTC private label industry and recently acquired by Watson Pharmaceutical, plans to leverage its extensive experience within the prescription medicine business to offer best-in-class options across store brand products.

July 10, 2013

DSN had the opportunity to speak with Christian Tadrus, who has been the pharmacist at Sam’s Health Mart in the Colombia, Mo. area, since 1997. Tadrus, a member of McKesson’s Sponsored Clinical Services pharmacy network, participates in a number of adherence support programs, including the award-winning Pharmacy Intervention adherence coaching program, StudyLink patient recruitment for clinical trials program, and the RxRapid Response pharmacist survey program.

July 18, 2012

As part of the Executive Viewpoint Series, DSN talked to Dan Mack — DSN expert blogger, EVP strategic sales at The Swanson Group and managing director of Mack Elevation Forum — discusses his unique perspective on what suppliers should focus on when engaging with retailers and what "blind spots" they should be wary of.

July 11, 2012

DSN talked to Cardinal Health SVP independent sales Steve Lawrence about the big news from Cardinal’s 2012 Retail Business Conference, including a best practices competition for its customers, its Women in Pharmacy program and Cardinal’s joint outreach program with the Ohio State University College of Pharmacy aimed at preventing prescription drug abuse.

March 5, 2012

Radio Health Journal's Reed Pence talks with DSN editor in chief Rob Eder; Walgreens president of pharmacy, health and wellness Kermit Crawford; Express Scripts senior director of public affairs Brian Henry; and former Walgreens pharmacy customer Virginia Greathouse about the causes and impact of the Walgreens-ESI dispute.

September 29, 2015

The Centers for Medicare and Medicaid Services has outlined its latest model for medication therapy management that it hopes will increase adherence and improve outcomes among Medicare Part D beneficiaries. 

September 29, 2015

"I take great pride in this company’s ability to reinvent itself starting in 2005," Kirby Lester president and CEO Garry Zage said. 

September 25, 2015

The National Association of Chain Drug Stores on Friday released a letter to the editor in response to a Sept. 5 article in The Washington Post about efforts to improve medication adherence through research and patient-focused strategies.

September 25, 2015

Health benefit plan cost trend rates for 2016 will increase for most medical plan options and increase substantially for prescription drug coverage to double-digit rates, according to forecasts compiled in the 2016 Segal Health Plan Cost Trend Survey, Segal’s nineteenth annual survey of health plan cost trends. Trend is the forecast of annual gross per capita claims cost increases.

September 24, 2015

The discount program’s website provides members online tools for finding participating pharmacies, as well as drug prices and availability. 

September 23, 2015

As both the Butte and Valley Fire raged in northern California, the state’s board of pharmacy held an emergency meeting to ensure that those affected by the blazes have access to medications.

September 23, 2015

CVS/pharmacy has also renewed its Medication Disposal for Safer Communities Program.

September 22, 2015

The Puget Sound Business Journal is reporting that Haggen is attempting to sell its $12.16 million in assets to Albertsons and Safeway. Some $8.9 million of those assets include customer and prescription records, as well as other pharmacy information. 

September 21, 2015

For the U.S. pharmaceutical market, 2015 is already shaping up to be another double-digit growth year in terms of prescription spend, and brand-name specialty drugs are big drivers of that growth.

September 21, 2015

A new CVS Health Research Insitute study, done in partnership with Brigham and Women’s Hospital, is offering insight into the reasons many patients don’t adhere to their medication regimen.

September 17, 2015

The iMedicare platform integrates with every pharmacy system, so pharmacies can identify patients eligible to choose a Medicare plan and generate a customized report within seconds.

September 17, 2015

Pager and Zipdrug’s alliance has begun rolling out in Manhattan.

September 16, 2015

If the future of health care can be summed up in one word, that word might be “connected.”


September 16, 2015

Although growth has been high for new specialty and brand-name drugs in the past year, generics continue to be a central part of the U.S. pharmaceutical market.